Julie Ostrander

About

Julie Ostrander is an Assistant Professor at the University of Minnesota, located in the United States. Her research focuses on the mechanisms of therapy resistance and tumorigenicity in breast cancer, with notable contributions to the understanding of metabolic treatments and cellular responses in the tumor microenvironment. Her recent publications include studies on various aspects of breast cancer, including the role of the CREB5 gene and glucocorticoid receptors in cancer progression.